- Clear All
- Remove theJAVMA Newsfilter JAVMA News
- Remove theResourcefilter Resource
- Remove thePharmacologyfilter Pharmacology
- Remove the2020filter 2020
- Remove the2016filter 2016
- Remove the2008filter 2008
- Remove theDrugs & vaccinesfilter Drugs & vaccines
- Remove theLegislation & regulationfilter Legislation & regulation
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove thePharmacies & prescriptionsfilter Pharmacies & prescriptions
- Remove theAnimal healthfilter Animal health
- Remove theState legislation & regulationfilter State legislation & regulation
resource
AVMA request: Commenting deadline for compounding
JAVMA news
FDA clarifying what constitutes minor use of drugs under MUMS Act
The Food and Drug Administration has proposed amending regulations relevant to the development of drugs for minor uses in major species to specify…
JAVMA news
More animal drugs for minor uses, minor species
The Minor Use and Minor Species Animal Health Act has so far played a part in the development process for new drugs to treat fish, shrimp, sheep, and…
JAVMA news
A time of transition at the FDA Center for Veterinary Medicine
Dr. Stephen F. Sundlof became the director of the FDA Center for Food Safety and Applied Nutrition, effective Jan. 7, after serving for more than a…
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients